BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25321845)

  • 1. Rapid involution of choroidal metastasis secondary to renal cell carcinoma with oral sunitinib.
    Chin EK; Almeida DR; Sacher BA; Boldt HC
    JAMA Ophthalmol; 2015 Jan; 133(1):109-10. PubMed ID: 25321845
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib.
    Fokt RM; Templeton A; Gillessen S; Ohlschlegel C; Schmid HP
    Urol Int; 2009; 83(1):122-4. PubMed ID: 19641373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sunitinib on renal cell carcinoma cutaneous metastasis.
    Liu SW; Guitart JG; Kuzel TM; Gandhi M; Lacouture M
    Int J Dermatol; 2009 Nov; 48(11):1269-70. PubMed ID: 20064194
    [No Abstract]   [Full Text] [Related]  

  • 4. Improvement of actinic keratosis associated with sunitinib therapy for metastatic renal cell carcinoma.
    Mir-Bonafé JM; Cañueto J; Bravo J; de Unamuno P
    Int J Dermatol; 2013 Nov; 52(11):1445-7. PubMed ID: 23432117
    [No Abstract]   [Full Text] [Related]  

  • 5. Complete cerebral response with sunitinib for metastatic renal cell carcinoma.
    Medioni J; Cojocarasu O; Belcaceres JL; Halimi P; Oudard S
    Ann Oncol; 2007 Jul; 18(7):1282-3. PubMed ID: 17675397
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose matters: the importance of appropriate dosing: a case report on sunitinib treatment in a patient with metastatic renal cell carcinoma.
    Bojic M; Schmidinger M
    Clin Genitourin Cancer; 2012 Dec; 10(4):277-9. PubMed ID: 22658385
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of psoriasis during sunitinib therapy for renal cell carcinoma.
    Narayanan S; Callis-Duffin K; Batten J; Agarwal N
    Am J Med Sci; 2010 Jun; 339(6):580-1. PubMed ID: 20421784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery.
    Gorin MA; Ekwenna O; Soloway MS; Ciancio G
    Urology; 2012 Feb; 79(2):e11. PubMed ID: 21676439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.
    De Vincenzo F; Zucali PA; Ceresoli GL; Colombo P; Simonelli M; Lorenzi E; Perrino M; Gianoncelli L; De Sanctis R; Graziotti P; Santoro A
    J Clin Oncol; 2011 Jun; 29(18):e529-31. PubMed ID: 21483010
    [No Abstract]   [Full Text] [Related]  

  • 10. Intermittent sunitinib for metastatic renal cell carcinoma.
    Venkatesan P
    Lancet Oncol; 2017 Mar; 18(3):e139. PubMed ID: 28163004
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma : A Case Report].
    Yoshinaga A; Kamata S
    Hinyokika Kiyo; 2015 May; 61(5):201-5. PubMed ID: 26087822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoadjuvant therapy for renal cancer].
    Thibault F; Rixe O; Meric JB; Renard-Penna R; Boostan H; Mozer P; Comperat E; Richard F; Bitker MO
    Prog Urol; 2008 Apr; 18(4):256-8. PubMed ID: 18501308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performing cytoreductive nephrectomy following targeted sunitinib therapy for metastatic renal cell carcinoma: a surgical perspective.
    Shaw GL; Hussain M; Nair R; Bycroft J; Beltran L; Green JS; Powles T; Peters JL
    Urol Int; 2012; 89(1):83-8. PubMed ID: 22614181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal brain metastases in clear cell renal cell carcinoma with complete response to sunitinib.
    Zeng H; Li X; Yao J; Zhu Y; Liu J; Yang Y; Qiang W
    Urol Int; 2009; 83(4):482-5. PubMed ID: 19996660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reverse side of the victory: flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases.
    Desar IM; Mulder SF; Stillebroer AB; van Spronsen DJ; van der Graaf WT; Mulders PF; van Herpen CM
    Acta Oncol; 2009; 48(6):927-31. PubMed ID: 19452305
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term response with sunitinib for metastatic renal cell carcinoma.
    Ronnen EA; Kondagunta GV; Ginsberg MS; Russo P; Motzer RJ
    Urology; 2006 Sep; 68(3):672.e19-20. PubMed ID: 16979716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metastasis to the Tongue from Renal Cell Carcinoma 10 Years after Nephrectomy : A Case Report].
    Wang C; Takeda K; Shiba M; Takayama H; Munakata S
    Hinyokika Kiyo; 2016 Aug; 62(8):407-10. PubMed ID: 27624106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.
    Salem ME; Shah SN; Elson P; Garcia JA; Wood LS; Medsinge A; Campbell S; Dreicer R; Rini BI
    Clin Genitourin Cancer; 2014 Apr; 12(2):117-23. PubMed ID: 24126239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of recurrent intracaval renal cell carcinoma effectively treated with sunitinib].
    Komeya M; Matsumoto T; Fujinami K; Senga Y; Asakura T; Goto A
    Hinyokika Kiyo; 2010 Sep; 56(9):499-503. PubMed ID: 20940524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous regression of choroidal metastasis from renal cell carcinoma.
    Hammad AM; Paris GR; van Heuven WA; Thompson IM; Fitzsimmons TD
    Am J Ophthalmol; 2003 Jun; 135(6):911-3. PubMed ID: 12788144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.